Showing results (201-210 of 537) with videos related to
Sort By:
Pageof 54
European Journal of Haematology|August 1, 1989
Prolonged effect of alpha-interferon after discontinuance of treatment in chronic myelogenous leukemia patientsG Alimena, E Montefusco, M Mancini, et al.Cancer|November 15, 1989
Candida colonization and systemic infection in neutropenic patients. A retrospective studyP Martino, C Girmenia, M Venditti, et al.American Journal of Epidemiology|March 15, 1994
Hair dye use and other risk factors for leukemia and pre-leukemia: a case-control study. Italian Leukemia Study GroupA Mele, M Szklo, G Visani, et al.Leukemia Research|January 1, 1982
B-cell acute lymphoid leukemia (ALL) with lymphoblasts expressing surface immunoglobulins only at relapseG De Rossi, G Alimena, C Guglielmi, et al.Cancer|August 1, 1990
Mitoxantrone for refractory and relapsed acute leukemiaW R Bezwoda, C Bernasconi, R M Hutchinson, et al.Leukemia|May 1, 1996
A phase II study of VP-16, intermediate-dose Ara-C and carboplatin (VAC) in advanced acute myelogenous leukemia and blastic chronic myelogenous leukemiaS Amadori, A Picardi, P Fazi, et al.British Journal of Haematology|November 1, 1996
Treatment of high-risk myelodysplastic syndromes with lymphoblastoid alpha interferonM C Petti, R Latagliata, G Avvisati, et al.Leukemia Research|January 1, 1984
PHA-ICC, ADCC and NK in patients with ANLL in CR: human fibroblastic interferon fails to increase NK-active cell frequencyL Fontana, G De Rossi, G De Sanctis, et al.Haematologica|December 29, 1998
Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapyG Martinelli, E Ottaviani, N Testoni, et al.Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1985
Turnover of alpha-2-antiplasmin in patients with acute promyelocytic leukemiaL H Kahle, G Avvisati, R J Lamping, et al.Pageof 54